OpenAlex
PricingAboutJobs
Log inGet started
Work

The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis

HTML

Year: 2009
Type: review
Source: Seminars in Arthritis and Rheumatism
DOI: 10.1016/j.semarthrit.2008.10.002
Author: Daniel E. Furst
Institution: University of California, Los Angeles
Language: English

Topic: Rheumatoid Arthritis Research and Therapies
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: rheumatoid arthritis, biologic therapy, infection risk, tuberculosis, TNF-alpha inhibitors, abatacept, rituximab, anakinra, infliximab, adalimumab, etanercept, pneumonia, vaccination, opportunistic infections, disease-modifying antirheumatic drugs
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2004670542
FWCI: 4.087
Cites: 139
Cited by: 315
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms